Clinical Trial Update: Prucalopride Treatment for Refractory Gastro-esophageal Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for prucalopride in refractory gastro-esophageal reflux disease (GERD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• PRUCALOPRIDE (Prucalopride)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: GERD | Phase 4 | Status: UNKNOWN